ATORVASTATIN CALCIUM
- Product NDC
- 61919-303
- 11-digit product format
- 619190303
- Labeler code
- 61919
- Product ID
- 61919-303_b8556fd4-1769-6175-e053-2995a90aaf6c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- DIRECT RX
- Application
- ANDA090548
- Marketing category
- ANDA
- Marketing start
- 2018-11-09
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-303-90 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 3 |
| 61919-303-30 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-303 | ATORVASTATIN CALCIUM (ATORVASTATIN) TABLET, FILM COATED [DIRECT RX] | 3 | Legacy NDC, 1 package rows | 20210108_7a3d0c78-f0a7-0706-e053-2991aa0ae9f7.zip |
| 61919-303 | ATORVASTATIN CALCIUM (ATORVASTATIN) TABLET, FILM COATED [DIRECT RX] | 2 | Legacy NDC, 1 package rows | 20180315_339af810-2a32-0804-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-303-30 | 61919030330 | 30 in 1 BOTTLE | | | | | Historical |
| 61919-303-90 | 61919030390 | 90 TABLET, FILM COATED in 1 BOTTLE (61919-303-90) | 2018-11-09 | 0000-00-00 | No | No | Current |